PRF Technologies Ltd. is a specialty pharmaceutical company based in Tel Aviv-Yafo, Israel, focused on the reformulation of established therapeutics. Its pipeline includes OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery, and PRF-110, a viscous clear oil-based solution instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. It was incorporated in 2007.